Mauro Ferrari

Prospects for microtechnology and nanotechnology in bioengineering of replacement microvessels.

Noninvasive diagnosis of incomplete endovascular aneurysm repair: D-dimer assay to detect type I endoleaks and nonshrinking aneurysms.

Biotechnology apprenticeship for secondary-level students: teaching advanced cell culture techniques for research.

Mechanical spectral signatures of malignant disease? A small-sample, comparative study of continuum vs. nano-biomechanical data analyses.

Interstitial stress and fluid pressure within a growing tumor.

Evaluation of the proximal aortic neck enlargement following endovascular repair of abdominal aortic aneurysm: 3-years experience.

T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions.

Clinical proteomics: written in blood.

Recommendations of the National Heart, Lung, and Blood Institute Nanotechnology Working Group.

Micropatterning of endothelial cells by guided stimulation with angiogenic factors.

Object-oriented design tools for supramolecular devices and biomedical nanotechnology.

Adhesion of microfabricated particles on vascular endothelium: a parametric analysis.

Opportunities for nanotechnology-based innovation in tissue proteomics.

Abdominal aortic aneurysm: contrast-enhanced US for missed endoleaks after endoluminal repair.

Tailoring width of microfabricated nanochannels to solute size can be used to control diffusion kinetics.

Type II lumbar endoleaks: hemodynamic differentiation by contrast-enhanced ultrasound scanning and influence on aneurysm enlargement after endovascular aneurysm repair.

Allelic genes involved in artery compliance and susceptibility to sporadic abdominal aortic aneurysm.

Cancer nanotechnology: opportunities and challenges.

Nanotechnology and tumor imaging: seizing an opportunity.

Release of biologically functional interferon-alpha from a nanochannel delivery system.

Nanovector therapeutics.

Endovascular repair of abdominal aortic aneurysms: analysis of aneurysm volumetric changes at mid-term follow-up.

Transcutaneous gases determination in diabetic critical limb ischemia.

Endovascular repair of an aorto-left renal vein fistula due to a ruptured abdominal aortic aneurysm after EVAR.

Medical nanotechnology: shortening clinical trials and regulatory pathways?

Morphologic instability and cancer invasion.

The molecular analysis of breast cancer utilizing targeted nanoparticle based ultrasound contrast agents.

Nanotechnologies for biomolecular detection and medical diagnostics.

Duodenal duplication cyst causing severe pancreatitis: imaging findings and pathological correlation.

Laparoscopy-assisted abdominal aortic aneurysm repair: early and middle-term results of a consecutive series of 122 cases.

Controlled-release microchips.

Selective binding and enrichment for low-molecular weight biomarker molecules in human plasma after exposure to nanoporous silica particles.

Nanoporous surfaces as harvesting agents for mass spectrometric analysis of peptides in human plasma.

Fractionation of serum components using nanoporous substrates.

Dynamic model of biomolecular diffusion through two-dimensional nanochannels.

Transcutaneous oxygen and carbon dioxide levels with iloprost administration in diabetic critical limb ischemia.

Physicochemically modified silicon as a substrate for protein microarrays.

Multiscale modeling of protein transport in silicon membrane nanochannels. Part 2. From molecular parameters to a predictive continuum diffusion model.

Multiscale modeling of protein transport in silicon membrane nanochannels. Part 1. Derivation of molecular parameters from computer simulations.

Mathematical modeling of cancer progression and response to chemotherapy.

Polymorphic analysis of the matrix metalloproteinase-9 gene and susceptibility to sporadic abdominal aortic aneurysm.

A robust nanofluidic membrane with tunable zero-order release for implantable dose specific drug delivery.

Cyclooxygenase-2 directly induces MCF-7 breast tumor cells to develop into exponentially growing, highly angiogenic and regionally invasive human ductal carcinoma xenografts.

Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI).

Antibiological barrier nanovector technology for cancer applications.

Biomedical nanotechnology for cancer.

Osmotic pressure beyond concentration restrictions.

Design maps for nanoparticles targeting the diseased microvasculature.

The mathematical engines of nanomedicine.

The transport of nanoparticles in blood vessels: the effect of vessel permeability and blood rheology.

Fast membrane osmometer as alternative to freezing point and vapor pressure osmometry.

Nanoncology.

nan'o.tech.nol'o.gy n.

Nanogeometry: beyond drug delivery.

Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications.

Seven challenges for nanomedicine.

Nanotechnology for breast cancer therapy.

The margination propensity of spherical particles for vascular targeting in the microcirculation.

Intravascular delivery of particulate systems: does geometry really matter?

Predicting drug pharmacokinetics and effect in vascularized tumors using computer simulation.

Evaluation of serial changes of pancreatic branch duct intraductal papillary mucinous neoplasms by follow-up with magnetic resonance imaging.

Nanomedicine--challenge and perspectives.

Application of physicochemically modified silicon substrates as reverse-phase protein microarrays.

The association of silicon microparticles with endothelial cells in drug delivery to the vasculature.

Ultrasonographic surveillance with selective CTA after endovascular repair of abdominal aortic aneurysm.

Multiparameter computational modeling of tumor invasion.

Prediction of drug response in breast cancer using integrative experimental/computational modeling.

Design of bio-mimetic particles with enhanced vascular interaction.

Straight talk with... Mauro Ferrari. Interviewed by Jon Evans.

Quantitative mechanics of endothelial phagocytosis of silicon microparticles.

Laparoscopic treatment of splenic artery aneurysms.

Conference scene: nanotechnology and medicine: the next big thing is really small.

Modulating cellular adhesion through nanotopography.

Mixed reality for robotic treatment of a splenic artery aneurysm.

Laparoscopic-assisted treatment of abdominal aortic aneurysm requiring suprarenal cross-clamping.

A new preoperative predictor of outcome in ruptured abdominal aortic aneurysms: the time before shock (TBS).

Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows.

Molecular modeling of glucose diffusivity in silica nanochannels.

Mesoporous silica chips for selective enrichment and stabilization of low molecular weight proteome.

Tailoring of the nanotexture of mesoporous silica films and their functionalized derivatives for selectively harvesting low molecular weight protein.

Enabling individualized therapy through nanotechnology.

Frontiers in cancer nanomedicine: directing mass transport through biological barriers.

Tailored porous silicon microparticles: fabrication and properties.

Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases.

Nanodevices in diagnostics.

Shaping the micromechanical behavior of multi-phase composites for bone tissue engineering.

Sustained small interfering RNA delivery by mesoporous silicon particles.

Multi-stage delivery nano-particle systems for therapeutic applications.

Cellular association and assembly of a multistage delivery system.

Drug delivery: Cellular Association and Assembly of a Multistage Delivery System Small 12/2010.

Nanochannel technology for constant delivery of chemotherapeutics: beyond metronomic administration.

Erratum: Cellular Association and Assembly of a Multistage Delivery System.

Cellular Association and Assembly of a Multistage Delivery System.

Mitotic trafficking of silicon microparticles.

Characterization of controlled bone defects using 2D and 3D ultrasound imaging techniques.

Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation.

Nanotechnology-enabled medicine.

Vectoring siRNA therapeutics into the clinic.

An integrated approach for the rational design of nanovectors for biomedical imaging and therapy.

Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells.

Intracellular trafficking of silicon particles and logic-embedded vectors.

Enhanced microcontact printing of proteins on nanoporous silica surface.

Combinatorial selection of DNA thioaptamers targeted to the HA binding domain of human CD44.

Identification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targeting.

Logic-embedded vectors for intracellular partitioning, endosomal escape, and exocytosis of nanoparticles.

Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast.

Biodegradable porous silicon barcode nanowires with defined geometry.

Direct evidence for catalase and peroxidase activities of ferritin-platinum nanoparticles.

Surface engineering on mesoporous silica chips for enriching low molecular weight phosphorylated proteins.

Nanotexture Optimization by Oxygen Plasma of Mesoporous Silica Thin Film for Enrichment of Low Molecular Weight Peptides Captured from Human Serum.

Proteomic analysis of serum opsonins impacting biodistribution and cellular association of porous silicon microparticles.

Near-infrared imaging method for the in vivo assessment of the biodistribution of nanoporous silicon particles.

Patient specific surgical simulator for the evaluation of the movability of bimanual robotic arms.

Case report of a successful treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and MRSA/vancomycin-resistant Enterococcus faecium cholecystitis by daptomycin.

Device for rapid and agile measurement of diffusivity in micro- and nanochannels.

Nanomedicine in cancer therapy: innovative trends and prospects.

Size of the nanovectors determines the transplacental passage in pregnancy: study in rats.

Probing the mechanical properties of TNF-α stimulated endothelial cell with atomic force microscopy.

Microfluidic enrichment of small proteins from complex biological mixture on nanoporous silica chip.

Agarose surface coating influences intracellular accumulation and enhances payload stability of a nano-delivery system.

Mesoporous silica as a membrane for ultra-thin implantable direct glucose fuel cells.

Thioaptamer conjugated liposomes for tumor vasculature targeting.

A low-voltage electrokinetic nanochannel drug delivery system.

E-selectin-targeted porous silicon particle for nanoparticle delivery to the bone marrow.

Optimizing particle size for targeting diseased microvasculature: from experiments to artificial neural networks.

What does physics have to do with cancer?

Multistage Mesoporous Silicon-based Nanocarriers: Biocompatibility with Immune Cells and Controlled Degradation in Physiological Fluids.

Multiscale modeling of circular and elliptical particles in laminar shear flow.

Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics.

Gadolinium metallofullerenol nanoparticles inhibit cancer metastasis through matrix metalloproteinase inhibition: imprisoning instead of poisoning cancer cells.

Value of multidetector computed tomography image segmentation for preoperative planning in general surgery.

Gated and near-surface diffusion of charged fullerenes in nanochannels.

Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution.

Molecular-targeted nanotherapies in cancer: enabling treatment specificity.

Bioengineering nanotechnology: towards the clinic.

Self-assembled zinc/copper hydroxide carbonates with tunable hierarchical nanostructure.

Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis.

Integration of biomechanical parameters in tetrahedral mass-spring models for virtual surgery simulation.

Sporadic or familial head neck paragangliomas enrolled in a single center: Clinical presentation and genotype/phenotype correlations.

Preparation, characterization, and cellular associations of silicon logic-embedded vectors.

Integrated intravital microscopy and mathematical modeling to optimize nanotherapeutics delivery to tumors.

Patient-specific surgical simulator for the pre-operative planning of single-incision laparoscopic surgery with bimanual robots.

Monitoring the progression of metastatic breast cancer on nanoporous silica chips.

Adult and umbilical cord blood-derived platelet-rich plasma for mesenchymal stem cell proliferation, chemotaxis, and cryo-preservation.

The preferential targeting of the diseased microvasculature by disk-like particles.

Outcomes of three years of teamwork on critical limb ischemia in patients with diabetes and foot lesions.

Computer guidance system for single-incision bimanual robotic surgery.

Efficacy and safety of a novel vascular closure device (Glubran 2 seal) after diagnostic and interventional angiography in patients with peripheral arterial occlusive disease.

Multistage delivery of chemotherapeutic nanoparticles for breast cancer treatment.

Methodist Debakey Cardiovascular Journal offers special thanks to guest editors Biana Godin and Mauro Ferrari.

Cardiovascular nanomedicine: a posse ad esse.

Inter-endothelial transport of microvectors using cellular shuttles and tunneling nanotubes.

Enhanced MRI relaxivity of Gd(3+) -based contrast agents geometrically confined within porous nanoconstructs.

Porous silicon nanocarriers for dual targeting tumor associated endothelial cells and macrophages in stroma of orthotopic human pancreatic cancers.

Human lung cancer cells grown in an ex vivo 3D lung model produce matrix metalloproteinases not produced in 2D culture.

Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells.

Characterization of nanochannel delivery membrane systems for the sustained release of resveratrol and atorvastatin: new perspectives on promoting heart health.

Hesperetin: an inhibitor of the transforming growth factor-β (TGF-β) signaling pathway.

Nanotechnologies and regenerative medical approaches for space and terrestrial medicine.

Evaluation of cell function upon nanovector internalization.

Cooperative, nanoparticle-enabled thermal therapy of breast cancer.

In silico vascular modeling for personalized nanoparticle delivery.

Serum peptidomic biomarkers for pulmonary metastatic melanoma identified by means of a nanopore-based assay.

Discoidal Porous Silicon Particles: Fabrication and Biodistribution in Breast Cancer Bearing Mice.

Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions.

Short and long term, in vitro and in vivo correlations of cellular and tissue responses to mesoporous silicon nanovectors.

A portrait of nanomedicine and its bioethical implications.

Multistage vectored siRNA targeting ataxia-telangiectasia mutated for breast cancer therapy.

Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery.

The physiology of cardiovascular disease and innovative liposomal platforms for therapy.

A case of concomitant occurrence of solitary fibrous tumor and urothelial high-grade invasive carcinoma of the urinary bladder.

Silicon micro- and nanofabrication for medicine.

How does a surgeon's brain buzz? An EEG coherence study on the interaction between humans and robot.

A physical sciences network characterization of non-tumorigenic and metastatic cells.

Identification of an inhibitory mechanism of luteolin on the insulin-like growth factor-1 ligand-receptor interaction.

Differential scanning calorimetry as a tool to investigate the transfer of anticancer drugs to biomembrane model.

Delivery of gene silencing agents for breast cancer therapy.

Validated RP-HPLC method for the simultaneous analysis of gemcitabine and LY-364947 in liposomal formulations.

Cellular communication via nanoparticle-transporting biovesicles.

Design maps for scaffold constructs in bone regeneration.

Porous silicon advances in drug delivery and immunotherapy.

Cognitive impairment and polidistrectual atherosclerotic disease in chylomicronemia syndrome: a case report.

Sustained zero-order release of intact ultra-stable drug-loaded liposomes from an implantable nanochannel delivery system.

Characterization of a nanogland for the autotransplantation of human pancreatic islets.

Engineering multi-stage nanovectors for controlled degradation and tunable release kinetics.

Mesoporous silicon particles for sustained gene silencing.

Modeling of nanotherapeutics delivery based on tumor perfusion.

Leveraging nanochannels for universal, zero-order drug delivery in vivo.

Polycation-functionalized nanoporous silicon particles for gene silencing on breast cancer cells.

High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics.

Secreted proteins from carotid endarterectomy: an untargeted approach to disclose molecular clues of plaque progression.

Circulating proteolytic products of carboxypeptidase N for early detection of breast cancer.

Live-cell single-molecule imaging reveals clathrin and caveolin-1 dependent docking of SMAD4 at the cell membrane.

Emerging nanotherapeutic strategies in breast cancer.

Shrinkage of pegylated and non-pegylated liposomes in serum.

Tumor vascular permeabilization using localized mild hyperthermia to improve macromolecule transport.

Polyarginine induces an antitumor immune response through binding to toll-like receptor 4.

Safety and pharmacokinetics of escalating doses of human recombinant nerve growth factor eye drops in a double-masked, randomized clinical trial.

Serum biomarkers for personalization of nanotherapeutics-based therapy in different tumor and organ microenvironments.

Bacteriophage Associated Silicon Particles: Design and Characterization of a Novel Theranostic Vector with Improved Payload Carrying Potential.

Distribution of innate ability for surgery amongst medical students assessed by an advanced virtual reality surgical simulator.

Antibody-free detection of Mycobacterium tuberculosis antigen using customized nanotraps.

Point-of-care technologies for molecular diagnostics using a drop of blood.

Transient mild hyperthermia induces E-selectin mediated localization of mesoporous silicon vectors in solid tumors.

Nanopore film based enrichment and quantification of low abundance hepcidin from human bodily fluids.

Colocalized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K/Akt/mTOR pathway.

Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications.

Transport properties of pancreatic cancer describe gemcitabine delivery and response.

Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.

The nano-plasma interface: Implications of the protein corona.

XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway.

Tumor lysing genetically engineered T cells loaded with multi-modal imaging agents.

Multifunctional gold nanorods for siRNA gene silencing and photothermal therapy.

Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1.

Bone marrow endothelium-targeted therapeutics for metastatic breast cancer.

Targeting the thyroid gland with thyroid-stimulating hormone (TSH)-nanoliposomes.

Capillary-wall collagen as a biophysical marker of nanotherapeutic permeability into the tumor microenvironment.

Multiscale patterning of a biomimetic scaffold integrated with composite microspheres.

USNCTAM perspectives on mechanics in medicine.

Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling.

Cefazolin-loaded mesoporous silicon microparticles show sustained bactericidal effect against Staphylococcus aureus.

EndoCAS (center for computer-assisted surgery).

Geometrical confinement of Gd(DOTA) molecules within mesoporous silicon nanoconstructs for MR imaging of cancer.

Redefining global health priorities: Improving cancer care in developing settings.

Noninvasive Transcutaneous Monitoring in Long-Term Follow-Up of Patients With Thromboangiitis Obliterans Treated With Intravenous Iloprost.

Safety of Nanoparticles in Medicine.

The effect of multistage nanovector targeting of VEGFR2 positive tumor endothelia on cell adhesion and local payload accumulation.

Degradation and biocompatibility of multistage nanovectors in physiological systems.

Patient-specific ultrasound liver phantom: materials and fabrication method.

Delivering Enhanced Testosterone Replacement Therapy through Nanochannels.

b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques.

Human equilibrative nucleoside transporter-1 knockdown tunes cellular mechanics through epithelial-mesenchymal transition in pancreatic cancer cells.

Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs.

Real-time intravital microscopy of individual nanoparticle dynamics in liver and tumors of live mice.

Transport Oncophysics in silico, in vitro, and in vivo. Preface.

Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer.

Osteoprogenitor cells from bone marrow and cortical bone: understanding how the environment affects their fate.

Clinical predictive circulating peptides in rectal cancer patients treated with neoadjuvant chemoradiotherapy.